• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.78% Nasdaq Down1.13%

    Interleukin Genetics, Inc. (ILIU)

    -Other OTC
    0.14 Down 0.01(6.67%) May 3, 3:57PM EDT
    ProfileGet Profile for:
    Interleukin Genetics, Inc.
    135 Beaver Street
    Waltham, MA 02452
    United States - Map
    Phone: 781-398-0700
    Fax: 781-398-0720
    Website: http://www.ilgenetics.com

    Details 
    Index Membership:N/A
    Sector:N/A
    Industry:N/A
    Full Time Employees:N/A

    Business Summary 

    Interleukin Genetics, Inc. focuses on the development and commercialization of personalized health products that help individuals to enhance and maintain their health through preventive measures in the United States. It offers PerioPredict, a genetic test to analyze genetic variations associated with inflammation and identify individuals with risk for periodontal disease. The company also provides weight management, bone health, heart health, nutritional needs, and wellness select genetic tests under the Inherent Health brand. It is also involved in the development of cardiovascular disease for drug development and prevention of secondary cardiovascular events; and osteoarthritis genetic tests to detect adult joint diseases. The company markets its Inherent Health brand of genetic tests through its e-commerce Website, and under contract with Amway and various regional weight management focused organizations. It has clinical research collaborations with Stanford University, the University of North Carolina, the Mayo Clinic, Brigham & Women’s Hospital, University of California, New York University Medical Center, University of Sheffield, Yonsei University Medical Center, Tongji Medical College, and Tuft’s University Medical Center for the research and development of genetic tests. The company was founded in 1986 and is headquartered in Waltham, Massachusetts.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Interleukin Genetics, Inc.

    Key Executives 
     PayExercised
    Mr. Mark B. Carbeau , 55
    Chief Exec. Officer and Director
    307.00K0.00
    Dr. Kenneth S. Kornman D.D.S., PH.D., 68
    Founder, Pres, Chief Scientific Officer, Sec. and Director
    408.00K0.00
    Mr. Stephen J. DiPalma M.B.A, 57
    Chief Financial Officer
    322.00K0.00
    Dr. Lynn Doucette-Stamm Ph.D.,
    VP of Devel. & Clinical Operations
    N/AN/A
    Mr. Joseph E. Zack , 64
    Chief Commercial Officer
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders